Business Context and Reporting Period
Company: CALIX, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 27, 2026
Event: Amendment to the Company's common stock repurchase program.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The only financial metric disclosed relates to capital allocation:
- Remaining Repurchase Authorization (as of Dec 31, 2025): $109.3 million
- New Authorization Amount: $125 million
- Total Repurchase Authorization (Post-Amendment): $425 million
Material Changes
On January 27, 2026, the Board of Directors amended the existing stock repurchase program to authorize an additional $125 million in purchases. This action increases the total authorized balance from the previous remaining amount of $109.3 million to a new total of $425 million.
Guidance, Outlook, and Management Commentary
Repurchase Program Terms:
- Methods: Purchases may be made via open market, privately negotiated transactions, or other methods compliant with SEC rules.
- Timing and Size: Dependent on prevailing stock prices, economic conditions, and capital allocation strategy.
- Obligation: The program does not obligate the Company to acquire a specific amount of stock.
- Discretion: The program may be suspended or discontinued at any time at the Company's discretion.
Risks and Contingencies: The filing does not disclose new material risks or contingencies beyond the standard discretion regarding the suspension of the repurchase program.
Investor Verification Checklist
- Verify the total remaining balance under the repurchase program in subsequent filings to track actual buyback execution.
- Review the attached Press Release (Exhibit 99.1) for any additional commentary on capital allocation strategy.
- Monitor future 8-K filings for any suspension or discontinuation of the program.